Skip to Contents

Hanmi Pharmaceutical

We only Offer Accurate and Transparent Management Information.

We offer accurate and transparent management information.

(1 million won, K-IFRS)

Balance Sheet Table
Category	2024	2023	2022	2021
Current assets	746,306	730,624	694,158	703,962
Non-current assets	1,274,534	1,168,045	1,230,428	1,232,767
Total Assets	2,020,840	1,898,668	1,924,586	1,936,729
Current liabilities	682,759	704,763	676,748	648,938
Non-current liabilities	97,330	93,695	238,611	359,531
Total Liabilities	780,089	798,458	915,359	1,008,469
Issued capital	32,027	31,405	30,765	30,196
Other equity	368,016	371,918	375,599	380,033
Retained earnings	680,888	581,979	452,298	396,916
Elements of other stockholder’s equity	3,962	-29,860	13,174	-4,230
Non-controlling interests	155,858	144,768	137,361	125,346
Total Equity	1,240,752	1,100,211	1,009,227	928,259
Total Equity and Liabilities	2,020,840	1,898,668	1,924,586	1,936,729

(1 million won, K-IFRS)

Income Statement Table
Category	2024	2023	2022	2021
Current assets	1,495,502	1,490,887	1,331,547	1,203,186
Non-current assets	678,465	661,638	612,994	570,433
Total Assets	817,037	829,249	718,553	632,752
Current liabilities	421,960	426,789	406,146	361,309
Non-current liabilities	178,891	181,769	154,317	146,027
Total Liabilities	216,186	220,691	158,090	125,416
Issued capital	12,197	7,247	7,964	9,229
Other equity	31,127	29,486	23,494	18,763
Retained earnings	19,680	25,404	14,127	10,727
Elements of other stockholder’s equity	45,673	28,588	27,138	22,912
Non-controlling interests	171,254	193,967	121,013	103,697
Total Equity	30,823	28,601	19,454	22,218
Total Equity and Liabilities	140,431	165,366	101,558	81,478
Current assets	34,771	-54,714	-6,757	25,647
Non-current assets	175,202	110,652	94,801	107,125

Credit Ratings Table
Agency	2024	2023	2022	2021
Korea Investors Service	A	A	A	A
NICE Investors Service	A	A	A	A

*Bond credit ratings are assigned when a bond is issued and the company is regularly assessed on a yearly basis